Literature DB >> 9022724

Specimen adequacy of ThinPrep sample preparations in a direct-to-vial study.

M Corkill1, D Knapp, J Martin, M L Hutchinson.   

Abstract

OBJECTIVE: To assess specimen adequacy of the ThinPrep slide preparation method in routine use. STUDY
DESIGN: Two studies, a feasibility study of 299 women and a clinical study of 499 women, were conducted. A broom-type collection device was used and rinsed directly into Pre-servCyt vials. Slides were prepared with the ThinPrep 2000 device, screened and classified according to the Bethesda System. The proportion of ThinPrep slides described as "Satisfactory But Limited By: No Endocervical Component (SBLB:No ECC)" was then compared to the proportion of SBLB: No ECC slides found on conventional smears in a previously conducted clinical trial of over 7,000 patients.
RESULTS: For the feasibility study the proportion of ThinPrep slides described as SBLB: No ECC was 9.36% as compared to the clinical trial combined rate of 9.4% for conventional smears. For the clinical study, 4.96% of ThinPrep slides were SBLB:No ECC as compared to the 4.4% SBLB:No ECC rate for conventional smears from the same clinical trial. The proportions were statistically equivalent for both studies.
CONCLUSION: It is expected that the rate of representing endocervical component will be maintained when the ThinPrep preparation method is used routinely in place of the conventional cytologic smear method.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022724     DOI: 10.1159/000332303

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  Cervical cancer screening: liquid based cytology may be preferred option for UK screening programme.

Authors:  Thomas Ind
Journal:  BMJ       Date:  2003-07-19

2.  Test execution variation in peritoneal lavage cytology could be related to poor diagnostic accuracy and stage migration in patients with gastric cancer.

Authors:  Young-Jun Ki; Sun-Hee Ji; Jae Seok Min; Sung-Ho Jin; Sunhoo Park; Hang-Jong Yu; Ho-Yoon Bang; Jong-Inn Lee
Journal:  J Gastric Cancer       Date:  2013-12-31       Impact factor: 3.720

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.